The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Camrelizumab plus famitinib in patients with recurrent or metastatic nasopharyngeal carcinoma: Data from an open-label, multicenter phase II basket study.
 
Ming-Yuan Chen
No Relationships to Disclose
 
Xiaozhong Chen
No Relationships to Disclose
 
Ximei Zhang
No Relationships to Disclose
 
Tianshu Liu
No Relationships to Disclose
 
Xicheng Wang
No Relationships to Disclose
 
Jinling Cai
No Relationships to Disclose
 
Shuni Wang
No Relationships to Disclose
 
Chunxia Chen
No Relationships to Disclose
 
Jia Fan
No Relationships to Disclose